Literature DB >> 15922487

Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China.

Min Shen1, Nathaniel Rothman, Sonja I Berndt, Xingzhou He, Meredith Yeager, Robert Welch, Stephen Chanock, Neil Caporaso, Qing Lan.   

Abstract

The aim of this study is to investigate the role of genetic polymorphisms in twelve folate metabolism genes on the risk of lung cancer in Xuan Wei, China, where the lung cancer mortality rate is among the highest and is mainly caused by indoor smoky coal emissions. A total of 122 incident primary lung cancer cases and 122 matched controls were enrolled. Three single nucleotide polymorphisms were associated with increased risk of lung cancer including homozygotes of the C allele of CBS Ala360Ala (OR: 4.02; 95% CI: 1.64-9.87), the 222Val allele of MTHFR (OR: 2.32; 95% CI: 1.34-4.03), and the C allele of SLC19A1 Pro232Pro (OR: 1.83; 95% CI: 1.02-3.28). The distribution of CBS and MTHFR haplotypes differed between cases and controls (P=0.002 and P=0.07, respectively). In summary, three genetic variants in folate metabolism genes are associated with an increased risk of lung cancer in Xuan Wei, China.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922487     DOI: 10.1016/j.lungcan.2005.04.002

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  26 in total

1.  Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers.

Authors:  Kristina G Flores; Christine A Stidley; Amanda J Mackey; Maria A Picchi; Sally P Stabler; Jill M Siegfried; Tim Byers; Marianne Berwick; Steven A Belinsky; Shuguang Leng
Journal:  Carcinogenesis       Date:  2012-06-04       Impact factor: 4.944

2.  One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.

Authors:  Kyoung-Mu Lee; Qing Lan; Anne Kricker; Mark P Purdue; Andrew E Grulich; Claire M Vajdic; Jennifer Turner; Denise Whitby; Daehee Kang; Stephen Chanock; Nathaniel Rothman; Bruce K Armstrong
Journal:  Hum Genet       Date:  2007-09-21       Impact factor: 4.132

3.  International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

Authors:  Therese Truong; Wiebke Sauter; James D McKay; H Dean Hosgood; Carla Gallagher; Christopher I Amos; Margaret Spitz; Joshua Muscat; Philip Lazarus; Thomas Illig; H Erich Wichmann; Heike Bickeböller; Angela Risch; Hendrik Dienemann; Zuo-Feng Zhang; Behnaz Pezeshki Naeim; Ping Yang; Shanbeh Zienolddiny; Aage Haugen; Loïc Le Marchand; Yun-Chul Hong; Jin Hee Kim; Eric J Duell; Angeline S Andrew; Chikako Kiyohara; Hongbing Shen; Keitaro Matsuo; Takeshi Suzuki; Adeline Seow; Daniel P K Ng; Qing Lan; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Vali Constantinescu; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Neil E Caporaso; Demetrius Albanes; Michael Thun; Maria Teresa Landi; Joanna Trubicka; Marcin Lener; Jan Lubinski; Ying Wang; Amélie Chabrier; Paolo Boffetta; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2010-01-27       Impact factor: 4.944

4.  Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma.

Authors:  Sujatha Suthandiram; Gin-Gin Gan; Shamsul Mohd Zain; Ping-Chong Bee; Lay-Hoong Lian; Kian-Meng Chang; Tee-Chuan Ong; Zahurin Mohamed
Journal:  Tumour Biol       Date:  2014-11-11

5.  Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.

Authors:  Yao Zhang; Guo Qiang Chen; Yong Ji; Bin Huang; Wei Sheng Shen; Li Chun Deng; Lei Xi; Xiang Ming Cao
Journal:  Mol Biol Rep       Date:  2012-01-04       Impact factor: 2.316

6.  Meta-analysis of methylenetetrahydrofolate reductase polymorphism and lung cancer risk in Chinese.

Authors:  Xin Wang; Kai Yue; Liran Hao
Journal:  Int J Clin Exp Med       Date:  2015-01-15

7.  SLC19A1 pharmacogenomics summary.

Authors:  Sook Wah Yee; Li Gong; Ilaria Badagnani; Kathleen M Giacomini; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-11       Impact factor: 2.089

8.  Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia.

Authors:  Catherine Metayer; Ghislaine Scélo; Anand P Chokkalingam; Lisa F Barcellos; Melinda C Aldrich; Jeffrey S Chang; Neela Guha; Kevin Y Urayama; Helen M Hansen; Gladys Block; Vincent Kiley; John K Wiencke; Joseph L Wiemels; Patricia A Buffler
Journal:  Cancer Causes Control       Date:  2011-07-12       Impact factor: 2.506

9.  Methylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysis.

Authors:  Renfang Mao; Yihui Fan; Yan Jin; Jing Bai; Songbin Fu
Journal:  J Hum Genet       Date:  2008-03-14       Impact factor: 3.172

10.  Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.

Authors:  Xiaoying Li; Minhua Shao; Shiming Wang; Xueying Zhao; Hongyan Chen; Ji Qian; Xiao Song; Jiucun Wang; Li Jin; Junjie Wu; Qiang Li; Chunxue Bai; Baohui Han; Zhiqiang Gao; Daru Lu
Journal:  Tumour Biol       Date:  2014-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.